MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Property and equipment,gross$14,136K Prepaid expenses andother current assets$9,590K Short-term marketablesecurities$588,753K Cash and cashequivalents$312,012K Other assets$3,301K Restricted cash$416K Property and equipment,net$5,457K Operating lease,right-of-use assets$18,078K Total current assets$910,355K Accumulated depreciation$8,679K Total assets$937,607K Total liabilities andstockholders equity$937,607K Total stockholdersequity$636,371K Total liabilities$301,236K Accumulated deficit-$1,188,420K Accumulated othercomprehensive income$355K Additional paid-in capital$1,734,882K Other liabilities$33K Operating leaseliabilities, net of current...$14,355K Convertible senior notes,net$222,895K Total currentliabilities$63,953K Common stock, 0.001 parvalue 300,000,000...$161K Preferred stock,value-Series BNon Voting...$35,563K Preferred stock,value-Series ANon Voting...$53,830K Operating leaseliabilities$1,547K Accrued expenses andother current...$52,902K Accounts payable$9,504K
Balance Sheet
source: myfinsight.com

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT)